Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) FCF Margin (2020 - 2025)

SOPHiA GENETICS's FCF Margin history spans 6 years, with the latest figure at 35.95% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 2308.0% to 35.95% in Q4 2025 year-over-year; TTM through Dec 2025 was 45.45%, a 2166.0% increase, with the full-year FY2025 number at 45.45%, up 2166.0% from a year prior.
  • FCF Margin hit 35.95% in Q4 2025 for SOPHiA GENETICS, up from 44.33% in the prior quarter.
  • Over the last five years, FCF Margin for SOPH hit a ceiling of 35.95% in Q4 2025 and a floor of 190.4% in Q3 2022.
  • Historically, FCF Margin has averaged 95.08% across 5 years, with a median of 76.54% in 2023.
  • Biggest five-year swings in FCF Margin: plummeted -14358bps in 2021 and later soared 11021bps in 2023.
  • Tracing SOPH's FCF Margin over 5 years: stood at 139.6% in 2021, then surged by 52bps to 67.62% in 2022, then decreased by -8bps to 72.89% in 2023, then grew by 19bps to 59.03% in 2024, then skyrocketed by 39bps to 35.95% in 2025.
  • Business Quant data shows FCF Margin for SOPH at 35.95% in Q4 2025, 44.33% in Q3 2025, and 51.45% in Q2 2025.